G8465 HCPCS Level II code: High or very high risk of recurrence of prostate cancer

G8465 is the HCPCS code for “High or very high risk of recurrence of prostate cancer” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

G8465

High or very high risk of recurrence of prostate cancer

Short description: High risk recurrence pro ca

HCPCS · United States

Medicare details

The indicators CMS publishes with G8465 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Carrier judgment
Medicare pricing
Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)
Type of service
Medical care
BETOS category
Specialist - other
Added
Jan 1, 2008

Where G8465 sits

  1. 1G codesProcedures and professional services
  2. 2Active code G8465High or very high risk of recurrence of prostate cancer

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code G8465 mean?

G8465 is the HCPCS code for “High or very high risk of recurrence of prostate cancer” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover G8465?

CMS lists G8465’s Medicare coverage as “Carrier judgment” and its pricing as “Service not separately priced by Part B (e.g., services not covered, bundled, used by Part A only, etc.)”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.

G8451Beta-blocker therapy for lvef <=40% not prescribed for reasons documented by the clinician (e.g., low blood pressure, fluid overload, asthma, patients recently treated with an…G8452Beta-blocker therapy not prescribedG8458Clinician documented that patient is not an eligible candidate for genotype testing; patient not receiving antiviral treatment for hepatitis c during the measurement period (e.g.…G8460Clinician documented that patient is not an eligible candidate for quantitative rna testing at week 12; patient not receiving antiviral treatment for hepatitis cG8461Patient receiving antiviral treatment for hepatitis c during the measurement periodG8464Clinician documented that prostate cancer patient is not an eligible candidate for adjuvant hormonal therapy; low or intermediate risk of recurrence or risk of recurrence not…G8473Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribedG8474Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed for reasons documented by the clinician (e.g., allergy, intolerance…G8475Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed, reason not givenG8476Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhgG8477Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhgG8478Blood pressure measurement not performed or documented, reason not given